Search results
Q1 2024 G1 Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoFirst, we've shown promising results...Phase three preserved two trial of trial acyclovir positive, they would be amongst the most significant data generated in the first line metastatic ...
Medicare Advantage networks should adapt, City of Hope exec says
Modern Healthcare· 4 days agoNarrow Medicare Advantage networks threaten access, however, a City of Hope executive said. AccessHope, which Duarte, California-based cancer provider City of Hope launched ...
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business Daily· 6 days agoTecartus treats forms of lymphoma and leukemia, while Trodelvy is a breast and bladder cancer...
The gender health gap: Why women’s health needs a rethink
The Drum· 4 days agoDespite headline achievements in the fight for equality, the small print shows that women spend 25%...
Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales By Investing.com
Investing.com· 3 days agoThe company's HIV product sales saw a 4% rise, while oncology product sales surged by 18%, primarily...
Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales
Investing.com· 4 days agoThe company's HIV product sales saw a 4% rise, while oncology product sales surged by 18%, primarily...
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Morningstar· 2 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
Most Homeless People Have Mental Health Disorders
Medscape· 4 days agoMost people experiencing homelessness have mental health disorders, according to a systematic review and meta-analysis. In an examination of studies that...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
ETF DAILY NEWS· 2 days agoFederated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing ...
